Quick Answer
EXAGEN INC. reported Net Income Loss of -$19.95 million for the year ending 2025.
- EXAGEN INC. showed a decrease of -32.0% in Net Income Loss from 2024 to 2025.
- This data is from EXAGEN INC.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$2.79 million | Q2 2018: -$2.15 million | Q3 2018: -$1.76 million | Q1 2019: -$2.70 million | Q2 2019: -$2.79 million | Q3 2019: -$3.14 million | Q1 2020: -$5.56 million | Q2 2020: -$3.36 million | Q3 2020: -$4.31 million | Q1 2021: -$6.21 million | Q2 2021: -$6.41 million | Q3 2021: -$7.18 million | Q1 2022: -$10.27 million | Q2 2022: -$14.67 million | Q3 2022: -$8.10 million | Q1 2023: -$7.69 million | Q2 2023: -$5.01 million | Q3 2023: -$5.42 million | Q1 2024: -$3.36 million | Q2 2024: -$2.97 million | Q3 2024: -$5.03 million | Q1 2025: -$3.75 million | Q2 2025: -$4.44 million | Q3 2025: -$7.09 million.
- Over the full 8 years of available data (2018 to 2025), EXAGEN INC.'s Net Income Loss has declined by 149.0%.
- Historical annual values: Fiscal year 2025: -$19.95 million | Fiscal year 2024: -$15.12 million | Fiscal year 2023: -$23.69 million | Fiscal year 2022: -$47.39 million | Fiscal year 2021: -$26.85 million | Fiscal year 2020: -$16.69 million | Fiscal year 2019: -$12.04 million | Fiscal year 2018: -$8.01 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: